Stefan Blankenberg
Latest contributions
Spotlight - TAVI durability: contemporary evidence and future directions
21 May 2026 – From EuroPCR 2026
Focusing on TAVI durability, this session reviews recent clinical evidence from randomized trials and large registries, examining procedural and device-related factors influencing long-term valve performance. It also discusses challenges in follow-up and implications for future trial designs and device monitoring.
Long-term TAVI durability: what are the yet unanswered questions?
21 May 2026 – From EuroPCR 2026
Nicolas Dumonteil and Stefan Blankenberg discuss the long-term durability of transcatheter heart valves and the implications for the future of TAVI.
Reviewing the latest evidence, including the 7-year results from PARTNER 3 and extended follow-up from Evolut Low Risk, they highlight the reassuring outcomes observed for death...
